Global Market Research Reports | JSB Market Research

Hotels (establishments that provide paid lodging and full guest services, typically with a continuous staff presence) market have seen moderate change in the recent years and is also expected to evolve in similar fashion in the near future. During 2013-2017 the overall room occupancy rate in Thailand inclined at a CAGR of 1.37% with 79.48% of occupancy rate in 2017. Considering the occupancy rate by segments, Budget hotels accounted for highest occupancy of 84.57% in 2017 while Upscale hotels segment registered lowest occupancy of 77.21%. The former registered a CAGR of 2.65% while the later recorded a CAGR of 1.40%. The  Thailand Hotels Industry Analysis  report on rooms and revenue Analytics provides deep dive data analytics on wide ranging Hotels business aspects including overall revenue by customer type - Business and Leisure, by type of hotel - Budget, Midscale, Upscale & Luxury, Room & Non-Room Revenues, Number of Establishments & Rooms and Guest In-Flow’s for t

"Food & Grocery Retailing in Finland, Market Shares,  Summary , and Forecasts to 2022", provides data for historic and forecast retail sales, and also includes information on the business environment and country risk related to Finland retail environment. In addition, it analyzes the key consumer trends influencing Finland food & grocery industry. Food & grocery sector sales dominated Finlands retail industry. The overall sector accounted for 47.6% of total sector sales and stood at 21 billion in 2017. Sector growth is mainly driven by growing household consumption in the country, supported by an improving labor market, population growth and inflation. What else does this report offer? - In-depth analysis of the latest trends in consumer shopping, covering the factors driving shopping, consumer insights, market dynamics - The report also details major retailers in food & grocery category group with their product proposition analysis and market positioning

This report brings together multiple data sources to provide a comprehensive overview of the Asia Pacific Seasonings, Dressings & Sauces sector. It includes market overview, high growth country analysis, health & wellness analysis, top brands, key distribution channels, packaging formats and case studies.   - The Asia-Pacific Seasonings, Dressings & Sauces (SDS) sector is the largest and the fastest growing SDS region globally in value terms during 2016-2021 - Condiment Sauces is the largest market in the Asia Pacific SDS sector, followed by the Herbs, Spices & Seasonings and Dressings markets - Amongst the different high potential countries in Asia-Pacific, Japan is the largest market in terms of value sales, while the Chinese SDS sector is expected to grow at the fastest pace during 2016-2021 - Increasing busy lifestyles of consumers who look for instant gravies and taste enhancers in a pursuit to reduce the cooking time and rising consumer preferences for various

Baxter International Inc (Baxter) is a provider of healthcare products, including dialysis in acute and chronic conditions, sterile intravenous solutions, parenteral nutrition therapies, generic injectable pharmaceuticals, infusion systems and devices, inhaled anesthetics, and surgical hemostat and sealant products. The companys products find application in hospitals, kidney dialysis centers, rehabilitation centers, nursing homes and clinics, besides patients at home under physician supervision. Baxter distributes its products through direct sales force and also through a network of independent distributors, drug wholesalers, specialty pharmacies and other alternative site providers. The company has operations in the Americas, the Middle East, Africa, Europe and Asia-Pacific. Baxter is headquartered in Deerfield, Illinois, the US. This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key informa

FLuphenazine Hydrochloride-EMEA Market Status and Trend Report 2013–2023   offers a comprehensive analysis on FLuphenazine Hydrochloride industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. VIEW FULL REPORT HERE - https://www.jsbmarketresearch.com/pharmaceuticals/fluphenazine-hydrochloride-emea-market-status-and-trend-report-2013-2023 No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include: Whole EMEA and Regional Market Size of FLuphenazine Hydrochloride 2013–2017, and development forecast 2018–2023 Main market players of FLuphenazine Hydrochloride in EMEA, with company and product introduction, position in the FLuphenazine Hydrochloride market Market status and development trend of FLuphenazine Hydrochloride by types and applications Cost and profit status of FLuphenazine Hydrochloride, and marketing st

Pancreatic cancer is set to become the second leading cause of cancer-related deaths in the US in 2020 after lung cancer, despite accounting for only 3% of new cancer diagnoses. Patients with advanced pancreatic cancer have a median survival of approximately 2.8-5.7 months, even in light of recent therapeutic innovations and elucidation of fundamental biological mechanisms of the disease. In the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) approximately two-thirds of patients are diagnosed with unresectable Stage III or Stage IV metastatic disease, and a significant proportion of resectable Stage III disease (85%) progresses to metastatic pancreatic cancer. Since 2013, the FDA and European Medicines Agency (EMA) have approved Celgenes Abraxane (nab-paclitaxel), followed by Ipsens Onivyde (irinotecan liposome injection). On the one hand, the addition of these novel therapeutic agents to existing regimens provides renewed hope to improve the treatment o

Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape provides a comprehensive overview of the emerging gene therapy market. The report discusses gene therapy and the technology behind gene editing, outlining the advantages, limitations and current evidence for the platforms under development. The report discusses relevant clinical studies targeting specific therapeutic indications and highlights examples of current challenges within the field, with a focus on therapies that target the eye, liver, and blood. Additionally, the report provides a background to the CRISPR patent litigation, a key factor within the gene editing company landscape. It provides profiles of six companies developing gene editing platforms, considers the gene therapy interests of the main pharmaceutical companies, and discusses current regulatory trends in the development of gene therapies. The report explores how emerging gene editing products will compete